Science Explorer Interactive view Map
Nonprofit · Algiers · Algeria

Association Shifa des Maladies NeuroMusculaires

Research works
1
▲ 820% vs 2013–17
Citations
4
3.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
89%
world 28%

Not ranked overall: Association Shifa des Maladies NeuroMusculaires is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Association Shifa des Maladies NeuroMusculaires publish most on?

By volume in 2022–2025: Parkinson's Disease Mechanisms and Treatments, Neurological diseases and metabolism, Cerebrovascular and genetic disorders and Academic Writing and Publishing.

  1. 1 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  2. 2 Neurological diseases and metabolism Neurology 0 works
  3. 3 Cerebrovascular and genetic disorders Neurology 0 works
  4. 4 Academic Writing and Publishing History and Philosophy of Science 0 works
  5. 5 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 0 works
  6. 6 Neurogenetic and Muscular Disorders Research Genetics 0 works
  7. 7 Congenital Diaphragmatic Hernia Studies Surgery 0 works
  8. 8 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available89.1%not open10.9%

World: 28% of research is openly available.

with international co-authors56.6%domestic only43.4%

World: 19% is written across borders.

How has Association Shifa des Maladies NeuroMusculaires's research output changed?

Output in 2018–2022 was 820% higher than in 2013–2017.

20152020

Other research institutions in Algiers

All research institutions in Algiers

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.